Jeroen van de Wetering
ICON plc · PRA Health Sciences · PRA-EDS
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Jeroen van de Wetering as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 10:27 UTC. Open this list on ClinicalTrials.gov
- Ph1NCT07259330 · To Determine the Effect of CYP Induction Following Administration of Nirogacestat in Healthy Adult Male ParticipantsSpringWorks Therapeutics, Inc., a healthcare company of Merck KGaA, Darmstadt, Germany · completed · Healthy · principal investigator
- Ph1NCT03493698 · A Fixed-Sequence, Drug-Drug Interaction Study Between Multiple Oral Doses of Inarigivir Soproxil and a Single Oral Dose of Midazolam in Healthy SubjectsF-star Therapeutics, Inc. · completed · Drug Interaction Potentiation · principal investigator
- Ph1NCT03478020 · Oral AQX-1125 and Combination Oral Contraceptive Drug-Drug Interaction StudyAquinox Pharmaceuticals (Canada) Inc. · completed · Healthy Volunteer · principal investigator
- Ph1NCT03320616 · EYP001a Food Effect Study in Subjects With Chronic Hepatitis B Virus (HBV) InfectionEnyo Pharma · completed · Hepatitis B, Chronic · principal investigator
- Ph1NCT02874248 · E4/DRSP Single and Multiple Dose PK and Early QT StudyEstetra · completed · Contraception · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 10:27 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
PubMed returned no clinical-trial papers for this author name.